Child and Adolescent Tuberculosis Artwork

The TBPod

The TBPod is a podcast for clinicians and policymakers caring for patients with tuberculosis. The podcasts present discussions with expert clinicians, researchers, policymakers and advocates about their work in the field of tuberculosis. Tuberculosis remains one of the leading causes of death worldwide, and is an important contributor to morbidity among migrants arriving in Australia and New Zealand. There are around 1300 reported cases of TB in Australia each year, and a further 300 in New Zealand. Included in these figures are cases of multi-drug resistant (MDR) TB which pose significant barriers to treatment and management of the disease. The Australian government has committed to the global elimination of TB by 2030, but to do so requires the development of innovative new strategies, based on high-quality research, that has national and international reach. These podcasts aim to engage and update those who are interested in the field of tuberculosis through discussions with leaders in the field of tuberculosis.

All Episodes

The TBPod

Child and Adolescent Tuberculosis

March 24, 2022 • Actnet

Tuberculosis is a global health priority and a major cause of child and adolescent morbidity and mortality. Approximately 1.5 million children and adolescents are infected with tuberculosis each year. Tuberculosis in children and adolescence is often overlooked by health providers and can be difficult to treat and diagnose. Professor Steve Graham will provide an overview of the current state of play in child and adolescent tuberculosis including the scale of the problem and our progress in reaching global targets.

Prof Graham is a Paediatrician with 20 years' experience in international child health including African and Asia-Pacific regions. He is a founding member of the Child Tuberculosis (TB) subgroup of World Health Organization (WHO) Stop TB Partnership, as well as being a member of the Strategic Technical Advisory Group on TB for the WHO, as well as research committees for Wellcome Trust, UK, and National Institutes of Health, USA.